The written plan for the STANFORD HRPP is comprised of a collection of policies, guidances,
and supporting documents governing human subject research and the protection of
participants. The policies are organized in the following 20 chapters of the HRPP Policy Manual:
|
|
|
|
|
|
|
|
| 4 |
Knowledge of Human Research Protection
Requirements |
| 5 |
Investigational or Unlicensed Test Articles |
| 6 |
Structure and Composition of IRBs |
| 7 |
Systematic Review |
| 8 |
Documentation of IRB Activities |
| 9 |
Risks to Research Participants |
| 10 |
Participant Recruitment and Selection |
| 11 |
Privacy and Confidentiality |
| 12 |
Informed Consent |
| 13 |
Multi-Site Research |
| 14 |
Protocol Director Standards |
| 15 |
Investigator Compliance |
| 16 |
HRPP Coverage of Sponsored Research |
| 17 |
Communication from Sponsors Affecting IRB Oversight |
| 18 |
Knowledge Benefit and Subject Interests |
| 19 |
Addressing Concerns of Research Participants |
| 20 |
Education and Outreach |
| |
Contents by Chapter |
|
|
1.1 |
|
1.2 |
|
1.3 |
|
1.4 |
Research Covered by the HRPP
|
1.5 |
Primary Officials, Administrative Units and Individuals of the HRPP |
1.6 |
Ethical and Legal Principles Governing Human Subject Research |
1.7 |
Scientific and Scholarly Validity Review and Ethics Review
|
|
|
|
2.1 |
|
| 2.2 |
Matching IRBs to Volume and Types of Human Research |
2.3 |
|
2.4 |
|
|
|
|
3.1 |
|
3.2 |
|
3.3 |
|
3.4 |
|
3.5 |
|
| 3.6 |
|
| 3.7 |
Investigators'
Conflicts of Interest |
| 3.8 |
Institutional
Conflict of Interest |
| 3.9 |
Non-Compliance
with HRPP Requirements |
| 3.10 |
Unanticipated Problems Involving Risks to Participants or Others (UPs), and Other Reportable Information |
| 3.11 |
Internal and External Reporting |
| 3.12 |
Assurance of
Compliance |
| 3.13 |
HRPP Quality
Improvement Activities |
| 3.14 |
Investigators'
Input to HRPP |
|
| 4 |
Knowledge of Human Research Protection
Requirements |
| 4.1 |
Education of Individuals Responsible for Human Research |
| 4.2 |
Required Training in Human Research Protections |
|
| 5 |
Investigational or Unlicensed Test Articles - Research with Drugs, Devices or Biologics |
| 5.1 |
Research with Test Articles |
| 5.2 |
Research with Drugs |
| 5.3 |
Research with Devices |
| 5.4 |
Radiology Devices and Radioactive Materials |
| 5.5 |
Research with Biologics |
| 5.6 |
Sponsor-Investigator Research |
| 5.7 |
Internal Handling of Test Articles |
| 5.8 |
Emergency Use of a Test Article |
| 5.9 |
"Compassionate Use" of a Test Article |
| 5.10 |
"Humanitarian Use" of a Device |
| 5.11 |
Planned Emergency Research |
|
| 6 |
Structure and Composition of IRBs |
| 6.1 |
Scope of IRB Authority |
| 6.2 |
Relationships Between the IRB and Others |
| 6.3 |
IRB Composition and Membership |
| 6.4 |
Scientific and Scholarly Expertise of IRB Members |
| 6.5 |
Obtaining Additional Expertise |
| 6.6 |
IRB Member and Consultant Conflicting Interest |
| 6.7 |
Assessment and Evaluation of the IRB |
| 6.8 |
IRB Roster and Quorum Requirements |
| 6.9 |
|
|
| 7 |
Systematic Review |
| 7.1 |
Protocol Review |
| 7.2 |
IRB Protocol Applications (eProtocol System) |
| 7.3 |
Submission, Preliminary Review and Assignment to IRBs |
| 7.4 |
Assignment of protocols to IRB members |
| 7.5 |
Protocol Review Material and Information |
| 7.6 |
Protocol Review - Pre-Review Parallel Process |
| 7.7 |
Protocols Presented at a Convened Meeting |
|
|
Documentation of IRB Activities |
| 8.1 |
IRB Protocol Files |
| 8.2 |
Record Retention |
| 8.3 |
IRB Minutes |
|
| 9 |
Risks to Research Participants |
| 9.1 |
Measuring and Minimizing Risk |
| 9.2 |
Data Monitoring Plan |
| 9.3 |
Risks to Vulnerable Populations |
| 9.4 |
Suspension or Termination of IRB approval |
|
| 10 |
Participant Recruitment and Selection |
| 10.1 |
Equitable Selection |
| 10.2 |
Review of Recruitment Methods, Advertising Materials and Payment |
|
| 11 |
Privacy and Confidentiality |
| 11.1 |
Protecting the Privacy of Participants |
| 11.2 |
Protecting the Confidentiality of Participant Information |
| 11.3 |
HIPAA - Health Insurance Portability and Accountability Act Regulations |
| 11.4 |
Confidentiality Breach - Unauthorized Release of Information |
|
| 12 |
Informed Consent and Assent |
| 12.1 |
Requirements for Informed Consent |
| 12.1.1 |
Elements of Informed Consent |
| 12.1.2 |
Additional Consent Requirements |
| 12.1.3 |
Consent Templates and Glossary of Lay Terms |
| 12.1.4 |
Consent Process |
| 12.2 |
Consent Procedures for Vulnerable and Other Special Populations Including Consent by a Legally Authorized Representative |
| 12.2.1 |
Adults with Impaired Decision-Making Capacity – “Decisionally impaired” |
| 12.2.2 |
Pregnant Women, Fetuses and Neonates |
| 12.2.3 |
Children and Consenting Minors |
| 12.2.4 |
Illiterate Participants |
| 12.2.5 |
Non-English Speaking Participants |
| 12.2.6 |
Prisoners |
| 12.3 |
IRB Review of the Consent Process, including Consent Documents |
| 12.4 |
Documentation of Informed Consent - Signature Requirements |
| 12.5 |
Waiver or Alteration of Informed Consent Requirements |
| 12.5.1 |
Waiver or Alteration of the Consent Process |
| 12.5.2 |
Waiver of Documentation of Consent - ("Waiver of Signature") |
| 12.6 |
Exceptions to Informed Consent in Emergency Situations |
| 12.7 |
Observation of the Consent Process |
|
| 13 |
Multi-Site Research |
| 13.1 |
Communication among IRBs in Multi-Site Research |
| 13.2 |
Information Management in Multi-Site Research |
|
| 14 |
Protocol Director Standards |
| 14.1 |
Identification and Management of Conflict of Interest |
| 14.2 |
Sound Study Design |
| 14.3 |
Detection of Harm, Minimization of Risks&Mitigation of Potential Injuries via Study Design,&During Research |
| 14.4 |
Recruitment |
| 14.5 |
Human Research Protection Resources |
| 14.6 |
Consent Process |
| 14.7 |
Response to Participants' Requests for Information and Complaints |
|
| 15 |
Investigator Compliance |
| 15.1 |
Qualification of Protocol Directors and Research Staff |
| 15.2 |
Reporting to the IRB - Unanticipated Problems Involving Risks to Participants or Others (UPs), and Other Reportable Information |
| 15.3 |
Research Oversight |
| 15.4 |
Data Monitoring Plan |
|
| 16 |
HRPP Coverage of Sponsored Research |
| 16.1 |
Agreement Includes Protection for Research Participants |
| 16.2 |
Provision Addressing Medical Care for Participants |
| 17 |
Communication from
Sponsors Affecting IRB Oversight |
| 18 |
Knowledge Benefit
and Participants' Interests |
| 18.1 |
Publication of Research Results |
| 18.2 |
Communicating Study Results
to Participants |
| 19 |
Addressing Concerns of Research
Participants |
| 20 |
Education and Outreach |
| 20.1 |
On-line Resources and Educational Materials |
| 20.2 |
Participant Research Inquiries |
| 20.3 |
Outreach |
| 20.4 |
Evaluation |